NCT03869905View on ClinicalTrials.gov

Aquamin® as an Adjuvant Intervention for Ulcerative Colitis

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 8, 2019

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Ulcerative Colitis
Interventions
DRUG

Aquamin®

4 capsules per day; 2 to be taken in the morning and 2 in the evening (containing approximately 800 mg calcium/day)

DRUG

Placebo first then Aquamin®

4 capsules per day; 2 to be taken in the morning and 2 in the evening

Trial Locations (1)

48109

The University of Michigan, Ann Arbor

All Listed Sponsors
lead

James Varani

OTHER

NCT03869905 - Aquamin® as an Adjuvant Intervention for Ulcerative Colitis | Biotech Hunter | Biotech Hunter